Project
Illumina Body Map 2, young vs old
Navigation
Downloads
Results for TWIST1_SNAI1
Z-value: 0.93
Motif logo
Transcription factors associated with TWIST1_SNAI1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TWIST1
|
ENSG00000122691.8 | twist family bHLH transcription factor 1 |
|
SNAI1
|
ENSG00000124216.3 | snail family transcriptional repressor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SNAI1 | hg19_v2_chr20_+_48599506_48599536 | 0.32 | 7.8e-02 | Click! |
| TWIST1 | hg19_v2_chr7_-_19157248_19157295 | 0.22 | 2.2e-01 | Click! |
Activity profile of TWIST1_SNAI1 motif
Sorted Z-values of TWIST1_SNAI1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_+_47596287 | 9.75 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
| chr19_+_35532612 | 9.74 |
ENST00000600390.1
ENST00000597419.1 |
HPN
|
hepsin |
| chr12_+_52626898 | 9.59 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
| chr4_-_77819002 | 8.59 |
ENST00000334306.2
|
SOWAHB
|
sosondowah ankyrin repeat domain family member B |
| chr9_+_17579084 | 8.29 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
| chrX_+_105969893 | 8.29 |
ENST00000255499.2
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
| chr16_+_4838393 | 7.29 |
ENST00000589721.1
|
SMIM22
|
small integral membrane protein 22 |
| chr7_+_73242069 | 6.78 |
ENST00000435050.1
|
CLDN4
|
claudin 4 |
| chr19_+_6464243 | 6.74 |
ENST00000600229.1
ENST00000356762.3 |
CRB3
|
crumbs homolog 3 (Drosophila) |
| chr19_-_3480540 | 6.61 |
ENST00000215531.4
|
C19orf77
|
chromosome 19 open reading frame 77 |
| chr7_+_73242490 | 6.49 |
ENST00000431918.1
|
CLDN4
|
claudin 4 |
| chr16_+_4845379 | 6.08 |
ENST00000588606.1
ENST00000586005.1 |
SMIM22
|
small integral membrane protein 22 |
| chr19_-_10697895 | 5.97 |
ENST00000591240.1
ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
| chr8_+_120220561 | 5.91 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
| chr19_-_54676884 | 5.73 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
| chr19_-_54676846 | 5.56 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
| chr21_-_42879909 | 5.55 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
| chr3_+_53528659 | 5.51 |
ENST00000350061.5
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
| chr17_+_52978185 | 5.38 |
ENST00000572405.1
ENST00000572158.1 ENST00000540336.1 ENST00000572298.1 ENST00000536554.1 ENST00000575333.1 ENST00000570499.1 ENST00000572576.1 |
TOM1L1
|
target of myb1 (chicken)-like 1 |
| chr17_+_37894179 | 5.34 |
ENST00000577695.1
ENST00000309156.4 ENST00000309185.3 |
GRB7
|
growth factor receptor-bound protein 7 |
| chr15_+_45722727 | 5.25 |
ENST00000396650.2
ENST00000558435.1 ENST00000344300.3 |
C15orf48
|
chromosome 15 open reading frame 48 |
| chr19_+_7660716 | 5.23 |
ENST00000160298.4
ENST00000446248.2 |
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3 |
| chr16_-_86542652 | 5.23 |
ENST00000599749.1
|
FENDRR
|
FOXF1 adjacent non-coding developmental regulatory RNA |
| chr2_+_149894968 | 5.14 |
ENST00000409642.3
|
LYPD6B
|
LY6/PLAUR domain containing 6B |
| chr18_-_71959159 | 5.10 |
ENST00000494131.2
ENST00000397914.4 ENST00000340533.4 |
CYB5A
|
cytochrome b5 type A (microsomal) |
| chr3_+_96533413 | 5.04 |
ENST00000470610.2
ENST00000389672.5 |
EPHA6
|
EPH receptor A6 |
| chrX_+_70443050 | 5.03 |
ENST00000361726.6
|
GJB1
|
gap junction protein, beta 1, 32kDa |
| chr21_-_42880075 | 4.98 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
| chr2_+_149895207 | 4.95 |
ENST00000409876.1
|
LYPD6B
|
LY6/PLAUR domain containing 6B |
| chr17_-_7165662 | 4.92 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
| chr1_+_3385085 | 4.87 |
ENST00000445297.1
|
ARHGEF16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
| chr15_+_50474385 | 4.78 |
ENST00000267842.5
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr16_-_3086927 | 4.76 |
ENST00000572449.1
|
CCDC64B
|
coiled-coil domain containing 64B |
| chr8_-_144815966 | 4.74 |
ENST00000388913.3
|
FAM83H
|
family with sequence similarity 83, member H |
| chr16_-_74808710 | 4.72 |
ENST00000219368.3
ENST00000544337.1 |
FA2H
|
fatty acid 2-hydroxylase |
| chr15_+_50474412 | 4.72 |
ENST00000380902.4
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr21_-_43187231 | 4.68 |
ENST00000332512.3
ENST00000352483.2 |
RIPK4
|
receptor-interacting serine-threonine kinase 4 |
| chr16_-_86542455 | 4.65 |
ENST00000595886.1
ENST00000597578.1 ENST00000593604.1 |
FENDRR
|
FOXF1 adjacent non-coding developmental regulatory RNA |
| chr7_-_73184588 | 4.63 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
| chr1_+_60280458 | 4.38 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
| chr2_-_219925189 | 4.34 |
ENST00000295731.6
|
IHH
|
indian hedgehog |
| chr1_-_40782938 | 4.32 |
ENST00000372736.3
ENST00000372748.3 |
COL9A2
|
collagen, type IX, alpha 2 |
| chr19_+_35609380 | 4.22 |
ENST00000604621.1
|
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr16_+_68771128 | 4.21 |
ENST00000261769.5
ENST00000422392.2 |
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial) |
| chr1_+_95285896 | 4.20 |
ENST00000446120.2
ENST00000271227.6 ENST00000527077.1 ENST00000529450.1 |
SLC44A3
|
solute carrier family 44, member 3 |
| chr1_-_156675535 | 4.18 |
ENST00000368221.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr16_+_23194033 | 4.08 |
ENST00000300061.2
|
SCNN1G
|
sodium channel, non-voltage-gated 1, gamma subunit |
| chr7_-_120497178 | 4.07 |
ENST00000441017.1
ENST00000424710.1 ENST00000433758.1 |
TSPAN12
|
tetraspanin 12 |
| chr15_+_41136586 | 3.97 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr7_+_73245193 | 3.97 |
ENST00000340958.2
|
CLDN4
|
claudin 4 |
| chr11_+_27062860 | 3.97 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr19_+_6464502 | 3.93 |
ENST00000308243.7
|
CRB3
|
crumbs homolog 3 (Drosophila) |
| chr18_+_47088401 | 3.91 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
| chr1_+_201979645 | 3.91 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr6_+_1312675 | 3.86 |
ENST00000296839.2
|
FOXQ1
|
forkhead box Q1 |
| chr2_-_133427767 | 3.86 |
ENST00000397463.2
|
LYPD1
|
LY6/PLAUR domain containing 1 |
| chr11_+_27062272 | 3.84 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr3_+_96533621 | 3.84 |
ENST00000542517.1
ENST00000506569.1 |
EPHA6
|
EPH receptor A6 |
| chr2_+_121493717 | 3.84 |
ENST00000418323.1
|
GLI2
|
GLI family zinc finger 2 |
| chr1_-_156675368 | 3.82 |
ENST00000368222.3
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr10_+_18429671 | 3.81 |
ENST00000282343.8
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
| chr19_+_46367518 | 3.80 |
ENST00000302177.2
|
FOXA3
|
forkhead box A3 |
| chr8_+_99076509 | 3.77 |
ENST00000318528.3
|
C8orf47
|
chromosome 8 open reading frame 47 |
| chr19_-_1490398 | 3.73 |
ENST00000588671.1
ENST00000300954.5 |
PCSK4
|
proprotein convertase subtilisin/kexin type 4 |
| chr11_+_27062502 | 3.72 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr17_-_39684550 | 3.71 |
ENST00000455635.1
ENST00000361566.3 |
KRT19
|
keratin 19 |
| chr17_-_39677971 | 3.70 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
| chr1_+_156030937 | 3.69 |
ENST00000361084.5
|
RAB25
|
RAB25, member RAS oncogene family |
| chr2_-_74669009 | 3.68 |
ENST00000272430.5
|
RTKN
|
rhotekin |
| chr2_+_128177458 | 3.66 |
ENST00000409048.1
ENST00000422777.3 |
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa) |
| chr2_+_14772810 | 3.64 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
| chr17_+_52978156 | 3.64 |
ENST00000348161.4
|
TOM1L1
|
target of myb1 (chicken)-like 1 |
| chr6_-_10419871 | 3.63 |
ENST00000319516.4
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr7_-_1595871 | 3.62 |
ENST00000319010.5
|
TMEM184A
|
transmembrane protein 184A |
| chr19_+_38755042 | 3.61 |
ENST00000301244.7
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr11_+_1855645 | 3.54 |
ENST00000381968.3
ENST00000381978.3 |
SYT8
|
synaptotagmin VIII |
| chr9_+_35673853 | 3.52 |
ENST00000378357.4
|
CA9
|
carbonic anhydrase IX |
| chr15_+_67547163 | 3.52 |
ENST00000335894.4
|
IQCH
|
IQ motif containing H |
| chr19_+_45281118 | 3.50 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr10_+_122216316 | 3.49 |
ENST00000398250.1
ENST00000439221.1 ENST00000398248.1 |
PPAPDC1A
|
phosphatidic acid phosphatase type 2 domain containing 1A |
| chr6_-_30043539 | 3.49 |
ENST00000376751.3
ENST00000244360.6 |
RNF39
|
ring finger protein 39 |
| chr11_-_130298888 | 3.48 |
ENST00000257359.6
|
ADAMTS8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8 |
| chr12_-_113574028 | 3.39 |
ENST00000546530.1
ENST00000261729.5 |
RASAL1
|
RAS protein activator like 1 (GAP1 like) |
| chr7_-_50132860 | 3.38 |
ENST00000046087.2
|
ZPBP
|
zona pellucida binding protein |
| chr1_-_201368707 | 3.33 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
| chr3_-_93747425 | 3.31 |
ENST00000315099.2
|
STX19
|
syntaxin 19 |
| chr7_-_122526499 | 3.30 |
ENST00000412584.2
|
CADPS2
|
Ca++-dependent secretion activator 2 |
| chr4_+_166300084 | 3.30 |
ENST00000402744.4
|
CPE
|
carboxypeptidase E |
| chr14_-_94789663 | 3.29 |
ENST00000557225.1
ENST00000341584.3 |
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
| chr10_-_82049424 | 3.26 |
ENST00000372213.3
|
MAT1A
|
methionine adenosyltransferase I, alpha |
| chr9_+_101569944 | 3.25 |
ENST00000375011.3
|
GALNT12
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12) |
| chr12_+_53342625 | 3.24 |
ENST00000388837.2
ENST00000550600.1 ENST00000388835.3 |
KRT18
|
keratin 18 |
| chr19_-_7939319 | 3.23 |
ENST00000539422.1
|
CTD-3193O13.9
|
Protein FLJ22184 |
| chr2_+_27665232 | 3.20 |
ENST00000543753.1
ENST00000288873.3 |
KRTCAP3
|
keratinocyte associated protein 3 |
| chr9_-_140142222 | 3.19 |
ENST00000344774.4
ENST00000388932.2 |
FAM166A
|
family with sequence similarity 166, member A |
| chr2_+_205410516 | 3.16 |
ENST00000406610.2
ENST00000462231.1 |
PARD3B
|
par-3 family cell polarity regulator beta |
| chr11_-_119993979 | 3.14 |
ENST00000524816.3
ENST00000525327.1 |
TRIM29
|
tripartite motif containing 29 |
| chr18_-_47721447 | 3.12 |
ENST00000285039.7
|
MYO5B
|
myosin VB |
| chr19_+_751122 | 3.11 |
ENST00000215582.6
|
MISP
|
mitotic spindle positioning |
| chr6_+_159291090 | 3.10 |
ENST00000367073.4
ENST00000608817.1 |
C6orf99
|
chromosome 6 open reading frame 99 |
| chr19_+_49055332 | 3.10 |
ENST00000201586.2
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1 |
| chr1_+_35247859 | 3.05 |
ENST00000373362.3
|
GJB3
|
gap junction protein, beta 3, 31kDa |
| chr1_+_6615241 | 3.04 |
ENST00000333172.6
ENST00000328191.4 ENST00000351136.3 |
TAS1R1
|
taste receptor, type 1, member 1 |
| chr5_+_63461642 | 3.01 |
ENST00000296615.6
ENST00000381081.2 ENST00000389100.4 |
RNF180
|
ring finger protein 180 |
| chr15_+_41136734 | 3.01 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr5_-_147211226 | 2.99 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr4_+_106816592 | 2.99 |
ENST00000379987.2
ENST00000453617.2 ENST00000427316.2 ENST00000514622.1 ENST00000305572.8 |
NPNT
|
nephronectin |
| chr9_+_133884469 | 2.99 |
ENST00000361069.4
|
LAMC3
|
laminin, gamma 3 |
| chr12_+_50355647 | 2.97 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
| chr1_+_6508100 | 2.97 |
ENST00000461727.1
|
ESPN
|
espin |
| chr9_+_103790991 | 2.93 |
ENST00000374874.3
|
LPPR1
|
Lipid phosphate phosphatase-related protein type 1 |
| chr7_-_50132801 | 2.92 |
ENST00000419417.1
|
ZPBP
|
zona pellucida binding protein |
| chr2_-_154335300 | 2.90 |
ENST00000325926.3
|
RPRM
|
reprimo, TP53 dependent G2 arrest mediator candidate |
| chr1_-_201368653 | 2.87 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
| chr16_+_84402098 | 2.86 |
ENST00000262429.4
ENST00000416219.2 |
ATP2C2
|
ATPase, Ca++ transporting, type 2C, member 2 |
| chr19_+_55795493 | 2.85 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr11_-_117667806 | 2.80 |
ENST00000527706.1
ENST00000321322.6 |
DSCAML1
|
Down syndrome cell adhesion molecule like 1 |
| chr16_+_68679193 | 2.78 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr9_-_112083229 | 2.78 |
ENST00000374566.3
ENST00000374557.4 |
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B |
| chr11_+_71903169 | 2.75 |
ENST00000393676.3
|
FOLR1
|
folate receptor 1 (adult) |
| chr5_+_76506706 | 2.75 |
ENST00000340978.3
ENST00000346042.3 ENST00000264917.5 ENST00000342343.4 ENST00000333194.4 |
PDE8B
|
phosphodiesterase 8B |
| chr2_+_159651821 | 2.75 |
ENST00000309950.3
ENST00000409042.1 |
DAPL1
|
death associated protein-like 1 |
| chr4_+_106816644 | 2.74 |
ENST00000506666.1
ENST00000503451.1 |
NPNT
|
nephronectin |
| chr19_-_49118067 | 2.73 |
ENST00000593772.1
|
FAM83E
|
family with sequence similarity 83, member E |
| chr4_-_177116772 | 2.71 |
ENST00000280191.2
|
SPATA4
|
spermatogenesis associated 4 |
| chr6_+_159290917 | 2.71 |
ENST00000367072.1
|
C6orf99
|
chromosome 6 open reading frame 99 |
| chr12_-_113573495 | 2.69 |
ENST00000446861.3
|
RASAL1
|
RAS protein activator like 1 (GAP1 like) |
| chr17_-_42345487 | 2.69 |
ENST00000262418.6
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group) |
| chr20_-_60942361 | 2.68 |
ENST00000252999.3
|
LAMA5
|
laminin, alpha 5 |
| chr2_+_27665289 | 2.67 |
ENST00000407293.1
|
KRTCAP3
|
keratinocyte associated protein 3 |
| chr5_+_170288856 | 2.67 |
ENST00000523189.1
|
RANBP17
|
RAN binding protein 17 |
| chr17_-_39258461 | 2.67 |
ENST00000440582.1
|
KRTAP4-16P
|
keratin associated protein 4-16, pseudogene |
| chr1_-_57285038 | 2.66 |
ENST00000343433.6
|
C1orf168
|
chromosome 1 open reading frame 168 |
| chr17_+_79989937 | 2.65 |
ENST00000580965.1
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
| chr1_+_95286151 | 2.65 |
ENST00000467909.1
ENST00000422520.2 ENST00000532427.1 |
SLC44A3
|
solute carrier family 44, member 3 |
| chr19_+_38755237 | 2.61 |
ENST00000587516.1
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr19_+_38755203 | 2.61 |
ENST00000587090.1
ENST00000454580.3 |
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr7_+_70597109 | 2.60 |
ENST00000333538.5
|
WBSCR17
|
Williams-Beuren syndrome chromosome region 17 |
| chr19_+_36359341 | 2.59 |
ENST00000221891.4
|
APLP1
|
amyloid beta (A4) precursor-like protein 1 |
| chrX_-_71525742 | 2.58 |
ENST00000450875.1
ENST00000417400.1 ENST00000431381.1 ENST00000445983.1 |
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 |
| chr3_-_50383096 | 2.56 |
ENST00000442887.1
ENST00000360165.3 |
ZMYND10
|
zinc finger, MYND-type containing 10 |
| chr17_+_52978107 | 2.56 |
ENST00000445275.2
|
TOM1L1
|
target of myb1 (chicken)-like 1 |
| chr11_-_64612041 | 2.52 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
| chr17_+_8243154 | 2.52 |
ENST00000328248.2
ENST00000584943.1 |
ODF4
|
outer dense fiber of sperm tails 4 |
| chr1_-_207119738 | 2.49 |
ENST00000356495.4
|
PIGR
|
polymeric immunoglobulin receptor |
| chr2_+_128177253 | 2.49 |
ENST00000427769.1
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa) |
| chr1_+_54359854 | 2.49 |
ENST00000361921.3
ENST00000322679.6 ENST00000532493.1 ENST00000525202.1 ENST00000524406.1 ENST00000388876.3 |
DIO1
|
deiodinase, iodothyronine, type I |
| chr8_-_53477968 | 2.48 |
ENST00000523939.1
ENST00000358543.4 |
FAM150A
|
family with sequence similarity 150, member A |
| chr1_-_209979465 | 2.47 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
| chr19_+_3708376 | 2.47 |
ENST00000539908.2
|
TJP3
|
tight junction protein 3 |
| chr1_-_209979375 | 2.46 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
| chr5_-_135528822 | 2.46 |
ENST00000607574.1
|
AC009014.3
|
AC009014.3 |
| chr6_-_132722604 | 2.46 |
ENST00000392401.3
ENST00000367963.3 |
MOXD1
|
monooxygenase, DBH-like 1 |
| chr9_+_74764278 | 2.45 |
ENST00000238018.4
ENST00000376989.3 |
GDA
|
guanine deaminase |
| chr17_-_39780819 | 2.44 |
ENST00000311208.8
|
KRT17
|
keratin 17 |
| chr14_-_67878917 | 2.42 |
ENST00000216446.4
|
PLEK2
|
pleckstrin 2 |
| chr11_-_70963538 | 2.40 |
ENST00000413503.1
|
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
| chr12_-_95942563 | 2.40 |
ENST00000549639.1
ENST00000551837.1 |
USP44
|
ubiquitin specific peptidase 44 |
| chr2_+_205410723 | 2.36 |
ENST00000358768.2
ENST00000351153.1 ENST00000349953.3 |
PARD3B
|
par-3 family cell polarity regulator beta |
| chr5_+_169532896 | 2.35 |
ENST00000306268.6
ENST00000449804.2 |
FOXI1
|
forkhead box I1 |
| chr2_+_234621551 | 2.34 |
ENST00000608381.1
ENST00000373414.3 |
UGT1A1
UGT1A5
|
UDP glucuronosyltransferase 1 family, polypeptide A8 UDP glucuronosyltransferase 1 family, polypeptide A5 |
| chr5_-_54281407 | 2.33 |
ENST00000381403.4
|
ESM1
|
endothelial cell-specific molecule 1 |
| chr18_+_29078131 | 2.33 |
ENST00000585206.1
|
DSG2
|
desmoglein 2 |
| chr20_-_62103862 | 2.32 |
ENST00000344462.4
ENST00000357249.2 ENST00000359125.2 ENST00000360480.3 ENST00000370224.1 ENST00000344425.5 ENST00000354587.3 ENST00000359689.1 |
KCNQ2
|
potassium voltage-gated channel, KQT-like subfamily, member 2 |
| chr11_+_111789580 | 2.31 |
ENST00000278601.5
|
C11orf52
|
chromosome 11 open reading frame 52 |
| chr17_-_46703826 | 2.31 |
ENST00000550387.1
ENST00000311177.5 |
HOXB9
|
homeobox B9 |
| chr6_-_3227877 | 2.30 |
ENST00000259818.7
|
TUBB2B
|
tubulin, beta 2B class IIb |
| chr7_+_89874483 | 2.30 |
ENST00000389297.4
ENST00000316089.8 |
C7orf63
|
chromosome 7 open reading frame 63 |
| chr18_+_29077990 | 2.28 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
| chr17_-_7197881 | 2.26 |
ENST00000007699.5
|
YBX2
|
Y box binding protein 2 |
| chr6_+_22569784 | 2.26 |
ENST00000510882.2
|
HDGFL1
|
hepatoma derived growth factor-like 1 |
| chr8_+_144821557 | 2.23 |
ENST00000534398.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
| chr8_+_144161874 | 2.23 |
ENST00000562505.1
|
RP11-520P18.5
|
Uncharacterized protein |
| chr6_-_31138439 | 2.21 |
ENST00000259915.8
|
POU5F1
|
POU class 5 homeobox 1 |
| chr1_+_31885963 | 2.21 |
ENST00000373709.3
|
SERINC2
|
serine incorporator 2 |
| chr17_-_78450398 | 2.20 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
| chr3_+_119421849 | 2.16 |
ENST00000273390.5
ENST00000463700.1 |
MAATS1
|
MYCBP-associated, testis expressed 1 |
| chr5_-_42811986 | 2.15 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
| chr6_-_28554977 | 2.14 |
ENST00000452236.2
|
SCAND3
|
SCAN domain containing 3 |
| chrX_+_72223352 | 2.14 |
ENST00000373521.2
ENST00000538388.1 |
PABPC1L2B
|
poly(A) binding protein, cytoplasmic 1-like 2B |
| chr11_+_7273181 | 2.13 |
ENST00000318881.6
|
SYT9
|
synaptotagmin IX |
| chr7_+_154002189 | 2.13 |
ENST00000332007.3
|
DPP6
|
dipeptidyl-peptidase 6 |
| chr2_+_115919049 | 2.12 |
ENST00000393147.2
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional) |
| chr5_+_68788594 | 2.11 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
| chr5_-_132113083 | 2.11 |
ENST00000296873.7
|
SEPT8
|
septin 8 |
| chr9_-_116861337 | 2.11 |
ENST00000374118.3
|
KIF12
|
kinesin family member 12 |
| chr7_-_142583506 | 2.10 |
ENST00000359396.3
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6 |
| chr17_+_37894570 | 2.09 |
ENST00000394211.3
|
GRB7
|
growth factor receptor-bound protein 7 |
| chr10_+_116853091 | 2.08 |
ENST00000526946.1
|
ATRNL1
|
attractin-like 1 |
| chr6_+_31950150 | 2.07 |
ENST00000537134.1
|
C4A
|
complement component 4A (Rodgers blood group) |
| chr1_-_47655686 | 2.06 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
| chr14_+_67999999 | 2.06 |
ENST00000329153.5
|
PLEKHH1
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
| chr11_+_6260298 | 2.06 |
ENST00000379936.2
|
CNGA4
|
cyclic nucleotide gated channel alpha 4 |
| chr19_-_36499521 | 2.05 |
ENST00000397428.3
ENST00000503121.1 ENST00000340477.5 ENST00000324444.3 ENST00000490730.1 |
SYNE4
|
spectrin repeat containing, nuclear envelope family member 4 |
| chr16_+_4838412 | 2.04 |
ENST00000589327.1
|
SMIM22
|
small integral membrane protein 22 |
| chr4_-_16085340 | 2.04 |
ENST00000508167.1
|
PROM1
|
prominin 1 |
| chr12_-_49259643 | 2.02 |
ENST00000309739.5
|
RND1
|
Rho family GTPase 1 |
| chr17_+_18280976 | 2.01 |
ENST00000399134.4
|
EVPLL
|
envoplakin-like |
| chr11_+_394196 | 2.00 |
ENST00000331563.2
ENST00000531857.1 |
PKP3
|
plakophilin 3 |
| chr17_+_73521763 | 2.00 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
Network of associatons between targets according to the STRING database.
First level regulatory network of TWIST1_SNAI1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 15.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 1.9 | 9.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.8 | 1.8 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 1.5 | 6.1 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 1.5 | 6.0 | GO:0032771 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 1.4 | 4.3 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 1.3 | 5.4 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 1.3 | 9.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.3 | 3.8 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 1.3 | 8.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.1 | 3.2 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 1.0 | 4.0 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.9 | 2.8 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.9 | 11.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.9 | 0.9 | GO:0072054 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.8 | 3.3 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.8 | 2.5 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.8 | 3.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.8 | 10.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.8 | 4.0 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.8 | 3.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.8 | 8.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.8 | 28.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.7 | 2.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.7 | 3.6 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.7 | 10.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.7 | 3.3 | GO:0030070 | insulin processing(GO:0030070) |
| 0.6 | 1.9 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
| 0.6 | 8.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.6 | 6.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.6 | 2.4 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
| 0.6 | 1.8 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.6 | 1.8 | GO:0035566 | regulation of metanephros size(GO:0035566) |
| 0.6 | 3.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.6 | 4.7 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.6 | 5.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.6 | 1.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.6 | 2.3 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.5 | 5.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.5 | 3.7 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.5 | 1.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.5 | 2.6 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.5 | 1.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.5 | 2.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.5 | 2.0 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.5 | 1.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.5 | 3.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.5 | 2.5 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.5 | 3.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.5 | 2.3 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 0.5 | 1.9 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.4 | 1.3 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.4 | 1.3 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.4 | 1.7 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.4 | 2.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.4 | 0.8 | GO:0021623 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.4 | 1.2 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 0.4 | 1.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.4 | 6.9 | GO:0015871 | choline transport(GO:0015871) |
| 0.4 | 2.0 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.4 | 4.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.4 | 3.1 | GO:0032439 | endosome localization(GO:0032439) |
| 0.4 | 2.7 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.4 | 2.2 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.4 | 1.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.4 | 2.9 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.4 | 3.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.4 | 1.4 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.4 | 1.8 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.3 | 2.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.3 | 4.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.3 | 3.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 | 1.0 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.3 | 1.6 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.3 | 1.6 | GO:0060023 | soft palate development(GO:0060023) |
| 0.3 | 5.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 | 1.3 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.3 | 3.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.3 | 2.6 | GO:0071104 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) response to interleukin-9(GO:0071104) |
| 0.3 | 0.6 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.3 | 0.9 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.3 | 2.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.3 | 0.9 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.3 | 1.2 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.3 | 1.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.3 | 0.9 | GO:0008089 | anterograde axonal transport(GO:0008089) axonal transport(GO:0098930) |
| 0.3 | 4.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.3 | 10.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.3 | 0.9 | GO:0060596 | mammary placode formation(GO:0060596) |
| 0.3 | 0.9 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.3 | 0.9 | GO:0038162 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.3 | 0.6 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.3 | 1.1 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.3 | 0.3 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.3 | 0.6 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.3 | 2.8 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.3 | 1.4 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.3 | 1.1 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.3 | 0.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.3 | 1.1 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.3 | 0.8 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.3 | 1.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.3 | 0.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.3 | 0.8 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.3 | 2.6 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.3 | 6.9 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.3 | 5.8 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.3 | 2.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.3 | 1.0 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.2 | 0.7 | GO:0050894 | determination of affect(GO:0050894) |
| 0.2 | 3.7 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.2 | 1.5 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.2 | 1.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 | 0.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 4.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.2 | 1.7 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.2 | 6.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.2 | 2.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 | 1.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 | 0.7 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.2 | 2.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.2 | 2.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.2 | 3.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.2 | 1.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.2 | 2.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 | 2.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.2 | 5.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 | 1.5 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.2 | 1.4 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.2 | 2.9 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.2 | 0.6 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.2 | 3.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 | 2.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 0.6 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 0.2 | 2.1 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.2 | 1.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.2 | 4.7 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.2 | 1.1 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.2 | 1.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.2 | 2.4 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 | 11.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.2 | 2.2 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.2 | 1.7 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.2 | 2.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.2 | 1.3 | GO:0050955 | thermoception(GO:0050955) |
| 0.2 | 3.2 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.2 | 0.9 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 | 0.5 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.2 | 4.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.2 | 17.0 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.2 | 1.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.2 | 5.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.2 | 1.2 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.2 | 2.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 | 0.8 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.2 | 0.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.2 | 1.8 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.2 | 1.7 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.2 | 1.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.2 | 1.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.2 | 0.8 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.2 | 2.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 0.5 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.2 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.2 | 0.5 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 0.2 | 0.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 | 8.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.2 | 2.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.2 | 0.8 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.1 | 0.6 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.1 | 4.6 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 2.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 1.5 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 | 0.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 | 1.3 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 | 1.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 3.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 3.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 0.7 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.1 | 5.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.1 | 1.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.1 | 4.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 1.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 4.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 0.3 | GO:2000018 | regulation of male gonad development(GO:2000018) positive regulation of male gonad development(GO:2000020) negative regulation of female gonad development(GO:2000195) |
| 0.1 | 2.6 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 0.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.1 | 2.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 0.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 | 0.9 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 | 17.8 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.9 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.7 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 | 4.6 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.1 | 0.5 | GO:1900673 | phenylpropanoid catabolic process(GO:0046271) olefin metabolic process(GO:1900673) |
| 0.1 | 0.7 | GO:0030421 | defecation(GO:0030421) |
| 0.1 | 0.4 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.1 | 0.6 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.1 | 3.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 3.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.1 | 0.3 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.1 | 0.5 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.1 | 0.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 | 1.5 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
| 0.1 | 7.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 | 2.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 4.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.1 | 0.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.1 | 1.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.1 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.1 | 3.8 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.1 | 1.0 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.1 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.1 | 0.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.1 | 0.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 | 5.6 | GO:0048599 | oocyte development(GO:0048599) |
| 0.1 | 0.8 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.1 | 0.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.1 | 0.6 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 | 0.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 | 0.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.1 | 2.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.1 | 1.7 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 1.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 | 1.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.1 | 2.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.1 | 0.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.1 | 7.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 0.1 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 | 1.8 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 1.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 1.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 | 1.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.1 | 2.6 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.1 | 0.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 1.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.1 | 0.5 | GO:0015853 | adenine transport(GO:0015853) |
| 0.1 | 0.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 0.9 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.1 | 0.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.9 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.1 | 2.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 | 0.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 0.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.1 | 1.3 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 | 1.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 | 1.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 3.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 2.6 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 | 0.4 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 3.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 | 0.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 2.8 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.1 | 4.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 5.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.1 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 1.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 0.5 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.1 | 2.7 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 | 1.5 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 | 0.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 1.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 1.4 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 | 1.5 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 2.2 | GO:0003341 | cilium movement(GO:0003341) |
| 0.1 | 0.2 | GO:1900369 | transcription, RNA-templated(GO:0001172) negative regulation of RNA interference(GO:1900369) |
| 0.1 | 1.2 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 2.2 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.1 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.1 | 4.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.1 | 2.8 | GO:0031102 | neuron projection regeneration(GO:0031102) |
| 0.1 | 0.2 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 | 0.5 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.1 | 1.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 1.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.1 | 1.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 0.3 | GO:0099624 | atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.1 | 0.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.1 | 0.3 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.1 | 3.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 | 0.8 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
| 0.1 | 1.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.1 | 0.6 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.1 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 | 0.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.3 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 | 0.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.1 | 1.2 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 1.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 0.6 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.5 | GO:0007631 | feeding behavior(GO:0007631) |
| 0.0 | 6.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 1.6 | GO:0001709 | cell fate determination(GO:0001709) |
| 0.0 | 0.3 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 | 0.7 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.0 | 0.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.0 | 0.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.0 | 1.5 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.0 | 0.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.0 | 0.2 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.0 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.0 | 0.4 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 | 1.2 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.0 | 0.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 | 1.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 | 0.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.0 | 0.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 | 1.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.9 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.0 | 0.4 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.0 | 1.0 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.0 | 0.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.0 | 0.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 | 2.1 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 | 0.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.0 | 0.3 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.0 | 0.6 | GO:0030238 | male sex determination(GO:0030238) |
| 0.0 | 0.8 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 | 0.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.0 | 1.0 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
| 0.0 | 0.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.0 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 | 2.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.0 | 0.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
| 0.0 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 1.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.0 | 0.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.0 | 0.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.0 | 1.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.0 | 0.9 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 4.4 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 | 0.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 | 0.6 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.7 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.0 | 1.0 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 | 1.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 0.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.0 | 1.2 | GO:0006312 | mitotic recombination(GO:0006312) |
| 0.0 | 0.7 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.0 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.0 | 0.2 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.0 | 0.9 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.0 | 1.8 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
| 0.0 | 0.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.0 | 0.5 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.0 | 0.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.0 | 0.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 | 0.5 | GO:0006999 | nuclear pore organization(GO:0006999) |
| 0.0 | 0.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.0 | 3.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
| 0.0 | 1.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 | 0.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 | 0.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 0.3 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 | 1.6 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
| 0.0 | 1.5 | GO:0090277 | positive regulation of peptide hormone secretion(GO:0090277) |
| 0.0 | 0.4 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
| 0.0 | 1.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.0 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.9 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
| 0.0 | 0.3 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.0 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.0 | 0.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 2.6 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.0 | 0.3 | GO:0010975 | regulation of neuron projection development(GO:0010975) |
| 0.0 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.0 | 0.1 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.0 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.0 | 0.4 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.0 | 0.9 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.0 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.0 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.0 | 0.8 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.0 | 0.8 | GO:1902930 | regulation of alcohol biosynthetic process(GO:1902930) |
| 0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 0.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.0 | 0.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 | 0.3 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 0.0 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.0 | 0.8 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 | 1.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 0.6 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.0 | 0.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 1.3 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.1 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.0 | 4.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.0 | 0.4 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 | 0.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
| 0.0 | 0.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.0 | 1.8 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.0 | 1.2 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.0 | 0.3 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.0 | 0.3 | GO:0001649 | osteoblast differentiation(GO:0001649) |
| 0.0 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.0 | 1.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.0 | 1.2 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
| 0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.0 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) regulation of grooming behavior(GO:2000821) |
| 0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.0 | 0.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 0.2 | GO:0051321 | meiotic cell cycle(GO:0051321) |
| 0.0 | 0.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.6 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
| 0.0 | 0.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.0 | 0.6 | GO:0006865 | amino acid transport(GO:0006865) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 2.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 1.0 | 3.1 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 1.0 | 5.7 | GO:0034678 | smooth muscle contractile fiber(GO:0030485) integrin alpha8-beta1 complex(GO:0034678) |
| 0.8 | 4.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.8 | 31.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.7 | 2.2 | GO:0001534 | radial spoke(GO:0001534) |
| 0.7 | 2.0 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 0.7 | 4.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.7 | 2.7 | GO:0030849 | autosome(GO:0030849) |
| 0.6 | 10.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.5 | 1.6 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.5 | 2.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.5 | 4.2 | GO:0070695 | FHF complex(GO:0070695) |
| 0.5 | 1.9 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.5 | 1.5 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.5 | 1.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.4 | 2.5 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.4 | 1.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.4 | 1.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.4 | 3.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.3 | 4.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.3 | 9.0 | GO:0005922 | connexon complex(GO:0005922) |
| 0.3 | 4.6 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 3.4 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.3 | 4.8 | GO:0045179 | apical cortex(GO:0045179) |
| 0.3 | 12.2 | GO:0030057 | desmosome(GO:0030057) |
| 0.3 | 5.8 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 2.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.3 | 1.3 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.3 | 8.5 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.3 | 4.1 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.2 | 3.7 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.2 | 6.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.2 | 9.0 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 2.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.2 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
| 0.2 | 18.9 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 8.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.2 | 40.8 | GO:0070160 | occluding junction(GO:0070160) |
| 0.2 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 1.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.2 | 1.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.2 | 0.8 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.2 | 1.1 | GO:1990357 | terminal web(GO:1990357) |
| 0.2 | 0.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.2 | 1.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 15.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.2 | 2.4 | GO:0005883 | neurofilament(GO:0005883) |
| 0.2 | 1.5 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 1.4 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.2 | 0.6 | GO:0016939 | plus-end kinesin complex(GO:0005873) kinesin II complex(GO:0016939) |
| 0.1 | 4.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 1.7 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 1.4 | GO:0071546 | pi-body(GO:0071546) |
| 0.1 | 20.2 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 3.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 4.3 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 3.4 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 3.2 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.1 | 3.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 2.3 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 2.8 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 1.1 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 1.1 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.1 | 2.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 4.4 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 2.2 | GO:0044453 | nuclear membrane part(GO:0044453) |
| 0.1 | 1.9 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
| 0.1 | 8.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 16.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 1.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 5.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 16.1 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.1 | 7.6 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 0.2 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.1 | 2.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.1 | 3.9 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.1 | 2.6 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.1 | 4.6 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 4.8 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 0.5 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.1 | 4.3 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.0 | 0.5 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.0 | 17.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 0.6 | GO:0097433 | dense body(GO:0097433) |
| 0.0 | 11.3 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 6.6 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 3.6 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 4.5 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 2.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.0 | 1.0 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.0 | 1.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 2.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.8 | GO:0042627 | chylomicron(GO:0042627) |
| 0.0 | 15.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 1.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.0 | 0.7 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 2.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 2.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.0 | 0.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 0.8 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.0 | 1.6 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 0.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.0 | 2.8 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 2.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.0 | 1.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 1.2 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.9 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 4.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 0.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.0 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.0 | 2.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.9 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 11.5 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 1.3 | 3.9 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 1.0 | 4.0 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 1.0 | 1.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 1.0 | 3.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.8 | 6.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.8 | 2.5 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.8 | 10.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.8 | 2.3 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.8 | 6.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.7 | 9.6 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.7 | 2.8 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.7 | 4.7 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.6 | 2.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.6 | 6.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.6 | 1.9 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.6 | 1.7 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.5 | 3.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.5 | 1.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.5 | 10.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.5 | 20.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.5 | 1.4 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.4 | 1.8 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.4 | 3.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.4 | 1.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.4 | 6.9 | GO:0005113 | patched binding(GO:0005113) |
| 0.4 | 9.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.4 | 1.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.4 | 2.5 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.4 | 12.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.4 | 2.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.4 | 4.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.4 | 3.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.4 | 10.0 | GO:0019841 | retinol binding(GO:0019841) |
| 0.4 | 1.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.4 | 11.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.4 | 1.5 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.4 | 2.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.4 | 2.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.4 | 1.4 | GO:0004040 | amidase activity(GO:0004040) |
| 0.4 | 5.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.4 | 3.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.3 | 1.7 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.3 | 1.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.3 | 9.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.3 | 4.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.3 | 1.0 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.3 | 1.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.3 | 4.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.3 | 2.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.3 | 2.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.3 | 0.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.3 | 7.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 1.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.3 | 2.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.3 | 1.2 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.3 | 1.5 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.3 | 2.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.3 | 1.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.3 | 1.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.3 | 2.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.3 | 1.0 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.2 | 1.2 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.2 | 0.9 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.2 | 1.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.2 | 1.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 1.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.2 | 4.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 3.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 1.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.2 | 2.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.2 | 5.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.2 | 1.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 5.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.2 | 3.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.2 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.2 | 3.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 2.6 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.2 | 0.5 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.2 | 0.8 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.2 | 3.0 | GO:0015250 | water channel activity(GO:0015250) |
| 0.2 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 1.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.2 | 2.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.2 | 2.2 | GO:0008430 | selenium binding(GO:0008430) |
| 0.2 | 2.6 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 6.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 3.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 2.7 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 3.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 1.0 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.1 | 1.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.1 | 1.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 2.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 4.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.1 | 0.7 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.1 | 3.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 3.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.1 | 0.5 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.1 | 12.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 18.1 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 3.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 2.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 3.4 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.1 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 0.3 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.1 | 1.7 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 0.3 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.1 | 1.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 1.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.1 | 1.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 1.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.1 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.1 | 3.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 1.1 | GO:0005497 | androgen binding(GO:0005497) |
| 0.1 | 2.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 16.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 1.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.1 | 3.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 1.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.1 | 2.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.5 | GO:0002046 | opsin binding(GO:0002046) |
| 0.1 | 4.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 0.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 0.4 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.1 | 1.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 1.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 1.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 1.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 0.9 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 1.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 1.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.1 | 0.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.1 | 0.2 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.1 | 2.6 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 7.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.1 | 1.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 0.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 1.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 1.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.1 | 0.5 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.1 | 0.3 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.1 | 2.3 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.7 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.1 | 3.4 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 1.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 1.7 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 3.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 1.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 1.5 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 0.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.1 | 1.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 0.6 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.1 | 2.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 0.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 0.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.1 | 6.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 1.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.2 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.1 | 1.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.1 | 0.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.1 | 0.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.1 | 0.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.1 | 1.1 | GO:0042805 | actinin binding(GO:0042805) |
| 0.1 | 0.8 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.1 | 0.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 1.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 2.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 0.4 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 0.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 0.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.1 | 0.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
| 0.1 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 0.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.1 | 0.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.0 | 0.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.0 | 0.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.0 | 1.4 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.0 | 1.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.0 | 1.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.0 | 0.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 3.2 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.0 | 1.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.0 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.0 | 1.5 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 2.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.0 | 7.7 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.0 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 0.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.0 | 1.3 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.0 | 0.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.0 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.0 | 1.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 1.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 6.3 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.0 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.0 | 1.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.0 | 1.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.0 | 0.4 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.0 | 0.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.0 | 1.7 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.0 | 1.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 1.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.3 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.0 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.0 | 0.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.0 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.0 | 1.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 1.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.0 | 0.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.0 | 2.4 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
| 0.0 | 0.5 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
| 0.0 | 6.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.0 | 0.5 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.0 | 0.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 1.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.0 | 0.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.0 | 0.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.0 | 3.1 | GO:0005506 | iron ion binding(GO:0005506) |
| 0.0 | 19.1 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 1.5 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.0 | 0.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.0 | 0.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.0 | 0.1 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.0 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 1.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.0 | 1.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 0.4 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.0 | 1.0 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 1.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 0.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.0 | 0.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.0 | 1.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.0 | 0.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 16.2 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 11.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.2 | 12.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 1.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 7.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 6.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 4.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 8.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 6.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 0.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.1 | 2.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 5.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 5.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.1 | 2.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 2.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 9.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 3.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 18.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
| 0.1 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.1 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 3.0 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 1.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 2.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 2.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 2.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 3.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.0 | 2.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 1.8 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 1.0 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 0.8 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 1.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 1.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 40.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.7 | 10.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.5 | 12.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 9.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.3 | 8.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.3 | 5.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 3.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 10.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.2 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 3.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 4.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.2 | 15.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 6.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 4.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 2.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 6.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 3.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 2.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.1 | 2.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 6.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 6.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.1 | 2.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 2.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 10.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 6.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 1.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 2.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 2.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 8.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.1 | 1.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 1.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.1 | 3.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 2.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 1.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 3.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 1.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 1.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 1.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 4.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 6.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 13.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 1.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 1.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.0 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.0 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.0 | 6.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 6.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 1.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 1.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 2.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 1.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.0 | 0.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 1.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 0.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 2.0 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.0 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 1.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 1.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.6 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.0 | 0.3 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
| 0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 3.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.0 | 0.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |